Derek Chalmers
2014
In 2014, Derek Chalmers earned a total compensation of $1.2M as President and Chief Executive Officer at Cara Therapeutics, a 174% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,000 |
|---|---|
| Option Awards | $546,694 |
| Salary | $440,000 |
| Total | $1,206,694 |
Chalmers received $546.7K in option awards, accounting for 45% of the total pay in 2014.
Chalmers also received $220K in non-equity incentive plan and $440K in salary.
Rankings
In 2014, Derek Chalmers' compensation ranked 6,749th out of 13,032 executives tracked by ExecPay. In other words, Chalmers earned more than 48.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,749 out of 13,032 | 48th |
Division Manufacturing | 2,478 out of 4,966 | 50th |
Major group Chemicals And Allied Products | 834 out of 1,686 | 51st |
Industry group Drugs | 657 out of 1,365 | 52nd |
Industry Pharmaceutical Preparations | 501 out of 1,043 | 52nd |
Source: SEC filing on April 27, 2016.
Chalmers' colleagues
We found four more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2014.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019